CRCA vs. GSY
CRCA (ProShares Ultra CRCL) and GSY (Invesco Ultra Short Duration ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while GSY is a Ultrashort Bond fund actively managed by Invesco. Both are actively managed. At a correlation of -0.01, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.22%/yr for GSY.
Performance
CRCA vs. GSY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than GSY's 1.59% return.
CRCA
- 1D
- -20.86%
- 1M
- -48.25%
- YTD
- -25.37%
- 6M
- -39.99%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GSY
- 1D
- 0.00%
- 1M
- 0.36%
- YTD
- 1.59%
- 6M
- 1.96%
- 1Y
- 4.54%
- 3Y*
- 5.45%
- 5Y*
- 3.65%
- 10Y*
- 2.86%
CRCA vs. GSY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.37% | -81.81% |
GSY Invesco Ultra Short Duration ETF | 1.59% | 1.88% |
Correlation
The correlation between CRCA and GSY is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | -0.01 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. GSY — Risk / Return Rank
CRCA
GSY
CRCA vs. GSY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Invesco Ultra Short Duration ETF (GSY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | GSY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 11.52 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 6.29 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 2.35 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 0.46 | -0.92 |
Drawdowns
CRCA vs. GSY - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than GSY's maximum drawdown of -12.14%. Use the drawdown chart below to compare losses from any high point for CRCA and GSY.
Loading charts...
Drawdown Indicators
| CRCA | GSY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -12.14% | -81.88% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.06% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -0.18% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -1.48% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -5.25% | — |
Current DrawdownCurrent decline from peak | -87.98% | 0.00% | -87.98% |
Average DrawdownAverage peak-to-trough decline | -69.26% | -2.39% | -66.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.01% | — |
Volatility
CRCA vs. GSY - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | GSY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.14% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.29% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.79% | 0.40% | +196.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.79% | 0.58% | +196.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.79% | 1.22% | +195.57% |
CRCA vs. GSY - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than GSY's 0.22% expense ratio.
Dividends
CRCA vs. GSY - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.32%, less than GSY's 4.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 2.32% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSY Invesco Ultra Short Duration ETF | 4.34% | 4.56% | 5.31% | 4.95% | 1.70% | 0.58% | 1.45% | 2.71% | 2.30% | 1.80% | 1.21% | 1.17% |
Frequently Asked Questions
CRCA and GSY have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GSY is cheaper at 0.22% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GSY is cheaper with a 0.22% expense ratio, compared with 0.95% for CRCA.
GSY has the higher dividend yield at 4.34%, compared with 2.32% for CRCA.
CRCA is categorized as Leveraged Equities, while GSY is Ultrashort Bond. They also come from different issuers: ProShares and Invesco. Their fees differ too: 0.95% for CRCA and 0.22% for GSY.
Find the right allocation for CRCA and GSY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer